US Black gay and bisexual men want more info in PrEP ads – but keep it simple
Cabotegravir long-acting PrEP out of reach for upper middle-income nations
Closure of HIV vaccine study shows how far we have to go
Daily PrEP is safe for the kidneys, although on-demand PrEP has slightly less impact
‘Stop having sex’: young women and clinic staff describe PrEP stigma in health facilities
PrEP chaos: how central Europe is suffering from inconsistent guidelines, random access, and healthcare stigma
South Africa to begin piloting injectable PrEP in early 2023
CD4 and white blood cell declines caused by islatravir are dose-related and reversible, but rule out using it for prevention
Rapid scale-up of PrEP in Ukraine this year, despite the war
